Johnson & Johnson, headquartered in New Brunswick, New Jersey, employs 131,900 people and focuses on healthcare through its Innovative Medicine and MedTech segments. Innovative Medicine targets various therapeutic areas, while MedTech offers products for orthopedic and cardiovascular interventions.
JNJ has been in the news recently: Bank of America recommends investing in stocks like Church & Dwight and Clorox due to their strong performance during market downturns. Additionally, Johnson & Johnson's TREMFYA® is the only IL-23 inhibitor approved for Crohn's disease, showing clinical remission in over 1,300 patients during Phase 3 trials.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
